Virdante Pharmaceuticals - Sialic Switch Assets - Ownership and Business Overview

Life ScienceCompany

Virdante Pharmaceuticals - Sialic Switch Assets Ownership

Who owns Virdante Pharmaceuticals - Sialic Switch Assets?

Virdante Pharmaceuticals - Sialic Switch Assets is owned by Momenta Pharmaceuticals. It was acquired on December 5, 2011.

Virdante Pharmaceuticals - Sialic Switch Assets Business Overview

Where is Virdante Pharmaceuticals - Sialic Switch Assets headquartered?

Virdante Pharmaceuticals - Sialic Switch Assets is headquartered in United States.

What sector is Virdante Pharmaceuticals - Sialic Switch Assets in?

Virdante Pharmaceuticals - Sialic Switch Assets is a life science company.

Life Science M&A Summary in 2011

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011. The largest life science acquisition in 2011 was Genzyme - which was acquired by Sanofi SA for $20.1B.

Join Mergr to view all 171 acquisitions of life science companies in 2011, including 23 acquisitions by private equity firms, and 148 by strategics.

Virdante Pharmaceuticals - Sialic Switch Assets


United States,

Virdante Pharmaceuticals - Sialic Switch assets is a provider of novel therapeutic treatments for autoimmune and inflammatory disorders.


 Subscribe to unlock this and 201,882
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Virdante Pharmaceuticals - Sialic Switch Assets

Life Science Companies , United States Companies